| Document |
Document Title |
|
WO/2019/124782A3 |
In a method for producing acetoin, butanediol, or butanol from ethanol according to the present invention, a cell-free catalysis method was used by designing an artificial synthetic pathway so that proteins of NOX, EtDH, FLS, BDH, and DD...
|
|
WO/2019/136560A1 |
The present application discloses biofunctional surfaces that have self-assembled monolayers of fluorine groups with "built-in" functional groups promote targeted cell and biomolecule binding to the surface while reducing non-specific bi...
|
|
WO/2019/140093A1 |
Methods are provided for cultivating fungi for scaled-up production of microbe-based products. Specifically, cultures of fungi, such as, e.g., Pisolithus tinctorius, are grown by aerobic submerged fermentation in liquid medium containing...
|
|
WO/2019/132549A1 |
The present invention relates to a method for preparing choline alfoscerate, usable as a food raw material, from phosphatidylcholine or lecithin, and a choline alfoscerate preparation method according to the present invention uses a spec...
|
|
WO/2019/130536A1 |
The present invention provides a method for detecting a monoclonal antibody in a sample, comprising the steps of: (a) capturing the monoclonal antibody in the sample and immobilizing the monoclonal antibody in a pore in a porous material...
|
|
WO/2019/130549A1 |
The present invention provides a method for detecting monoclonal antibodies in a sample, the method including (a) a step for trapping monoclonal antibodies in a sample and immobilizing the same in pores of a porous substance, (b) a step ...
|
|
WO/2019/059624A9 |
The present invention relates to a composition for in vitro production of trans-resveratrol, the composition comprising purified photosynthetic membrane vesicles and a trans-resveratrol biosynthesis-related enzyme, and to a production me...
|
|
WO/2019/123886A1 |
An array including a plurality of tubes disposed in contact such that the axial directions thereof are parallel to each other and a test substance disposed inside at least one of the plurality of tubes; the plurality of tubes is made of ...
|
|
WO/2019/126627A1 |
Compositions of the present disclosure include a first dCas9-FokI-sgRNA complex and a second dCas9-FokI-sgRNA complex. The first sgRNA is configured to target a first side of a genomic fusion site and the second sgRNA is configured to ta...
|
|
WO/2019/124782A2 |
In a method for producing acetoin, butanediol, or butanol from ethanol according to the present invention, a cell-free catalysis method was used by designing an artificial synthetic pathway so that proteins of NOX, EtDH, FLS, BDH, and DD...
|
|
WO/2019/117242A1 |
[Problem] To provide a microorganism-immobilized carrier to which a microorganism can easily adhere, and which enables reduction in the manufacturing cost of the microorganism-immobilized carrier and in the running cost of a device using...
|
|
WO/2019/115647A1 |
The invention relates to the uses of a new characterized TET protein showed restricted to N-terminus glycine residues exopeptidase. The invention also relates to a method comprising said use of said new characterized TET protein as a N-t...
|
|
WO/2019/115603A1 |
The present invention relates to the use of a TET protein as a N-terminus aromatic amino acid residues specific exopeptidase, said TET protein comprising the amino acid sequence as set forth in SEQ ID NO: 1.
|
|
WO/2019/112515A1 |
The present invention provides a method of producing a product for waste degradation, a product for waste degradation, an isolated microbial strain, a substantially pure culture of the isolated microbial strain, a microbial consortium or...
|
|
WO/2019/104144A1 |
Methods and co-cultures for biodegrading contaminants are described. A method can include contacting a contaminated substance with a microbial mixture under anaerobic conditions and causing degradation of contaminants by metabolism of th...
|
|
WO/2019/103130A1 |
Provided is a biogas measurement device capable of sampling a biogas continuously and measuring a target substance from the sampled biogas instantaneously and over time. Included is a skin gas measurement device comprises a biogas collec...
|
|
WO/2019/102838A1 |
A chitin-degrading enzyme composition comprising chitinase which is a chitin-degrading enzyme hydrolyzing chitin, silica or a silica-containing substance and a nitrogen-containing heterocyclic compound which is a heterocyclic compound co...
|
|
WO/2019/101951A1 |
The invention provides enzyme particles comprising an immobilized lipolytic enzyme, a siliceous material, an organic filter aid, and a water-soluble polyol selected from carbohydrates and sugar alcohols. The particles are suitable for en...
|
|
WO/2019/098256A1 |
The present invention provides a nerve cell device in which early observation of nerve activity (spikes, bursts, and the like) is made possible and the measured electric strength is increased by cultivating nerve cells upon a cell scaffo...
|
|
WO/2019/097921A1 |
The present invention addresses the problem of providing a degrading bacteria-immobilized carrier which supports 1,4-dioxane-degrading bacteria, and a biodegradation treatment method and biodegradation treatment device for organic compou...
|
|
WO/2019/099644A1 |
Disclosed herein is a method of utilizing an enzyme in a nucleic acid manipulation process, the method comprising: a) transforming a microorganism with a non-native enzyme; b) inducing expression of the enzyme in the microorganism, there...
|
|
WO/2019/093439A1 |
To provide an immunoglobulin-binding protein which has improved chemical stability, in particular, stability to alkalis. This problem can be solved by substituting an amino acid residue at a specific position in an immunoglobulin-binding...
|
|
WO/2019/090783A1 |
Provided are a networked cationic polymer and preparation thereof. Said networked cationic polymer has a backbone that involves aromatically conjugated imine linkages and possesses sufficient network cavity to load nucleic acids intra-mo...
|
|
WO/2019/092294A1 |
The present invention relates to an enzymatic derivative comprising a hydrolytic enzyme, preferably naringinase, which is immobilised by covalent bonding on laminar zeolites, to a method for producing same and to the uses thereof, prefer...
|
|
WO/2019/087828A1 |
The purpose of the present invention is to provide composite particles for imaging that have high biodegradability after imaging. To achieve the above purpose, the composite particles for imaging according to the present invention are co...
|
|
WO/2019/059624A3 |
The present invention relates to a composition for in vitro production of trans-resveratrol, the composition comprising purified photosynthetic membrane vesicles and a trans-resveratrol biosynthesis-related enzyme, and to a production me...
|
|
WO/2019/088258A1 |
[Problem] To develop a photodegradable cell immobilization agent having superior cell immobilization ability. [Solution] This photodegradable cell immobilization agent is for immobilizing a predetermined target cell onto a base material,...
|
|
WO/2019/071039A1 |
The present disclosure provides systems and methods for making a hydrogel comprising a cell, cell nucleus, or one or more components derived from a cell or cell nucleus. A method for making a hydrogel may comprise providing a cell or cel...
|
|
WO/2019/070992A1 |
Metastable state spore incubation mixing systems are described. An example system includes a spore container to store spores, a nutrient container, an arrangement of valves and tubes, a reciprocating pump, a mixing tube, and a holding ta...
|
|
WO/2019/069809A1 |
Provided is a carrier, etc., for protein immobilization with which it is possible to adequately manifest the activity of the immobilized protein. A carrier for protein immobilization for immobilizing the amino groups of a protein, the ca...
|
|
WO/2019/059624A2 |
The present invention relates to a composition for in vitro production of trans-resveratrol, the composition comprising purified photosynthetic membrane vesicles and a trans-resveratrol biosynthesis-related enzyme, and to a production me...
|
|
WO/2019/057914A1 |
The present invention relates to a composition comprising a continuous aqueous phase and at least one capsule, said capsule comprising a core, which is liquid or at least partly gelled or at least partly thixotropic, and at least one out...
|
|
WO/2019/057958A1 |
The present invention relates to polymeric particles comprising a biodegradable polymer, and at least one microorganism in a total concentration of at least 108 CFU/g dry weight that is stable for at least 35 weeks at 30°C and optionall...
|
|
WO/2019/050389A1 |
The present invention relates to a method of producing an article suitable for use as a bioflocculant or a biosorbent for waste material and heavy metal removal. The method preferably comprises the steps of growing cells of a marine fila...
|
|
WO/2019/050978A1 |
Disclosed herein are compositions and methods for preparation and use of protein therapeutics, and more particularly protein clusters or backpacks having a plurality of therapeutic protein monomers reversibly crossed-linked by biodegrada...
|
|
WO/2019/039777A1 |
The present invention relates to a porous silica carrier for stabilizing proteins and enzymes, and a production method and use thereof. A silica carrier according to the present invention is harmless to the human body, is based on silica...
|
|
WO/2019/028666A1 |
Disclosed is a method for preparing levetiracetam, comprising the following steps: performing resolution under the action of an ester hydrolase using 2-halobutyrate as a raw material to obtain (S)-2-halobutyrate, reacting with 2-pyrrolid...
|
|
WO/2019/023555A1 |
Provided herein are methods and compositions related to polymer-coated bacteria.
|
|
WO/2019/021274A1 |
The present invention provides polynucleotide constructs with at least one disruption or tearing responsive promoter and at least one sequence encoding a fiber-forming protein. The invention further provides a cell comprising such a cons...
|
|
WO/2019/013100A1 |
Provided is a composite composition which is capable of stabilizing biomolecules. A composite composition according to one embodiment of the present invention contains biomolecules and anion-modified cellulose nanofibers that have a cell...
|
|
WO/2019/014178A1 |
Various embodiments of the present technology provide methods and systems for soil enrichment. The systems may comprise a bioreactor system coupled to an initial treatment system for the cultivation of a live microorganism culture contai...
|
|
WO/2019/006908A1 |
A nanometer photocatalyst-microbe composite multilayer light transmission combination carrier, comprising a plurality of wave-shaped organic glass plates (1), a serial rod fixing rack (4), middle-through elastic spacers (5), and fixing s...
|
|
WO/2019/004446A1 |
The present invention addresses the problem of providing an excellent treatment agent for lysosomal storage disease. Provided is a treatment agent for lysosomal storage disease, containing a cellular structure that includes multiple bioc...
|
|
WO/2019/006077A1 |
Described are compositions and methods relating to low density enzyme-containing particles for inclusion in cleaning and other low-water compositions. The particles remain in suspension without settling, and release active enzyme upon di...
|
|
WO/2019/002658A3 |
The present invention relates to a method for the enzymatic synthesis of long-chain fatty acid alkyl esters in the presence of an alcohol and of an enzymatic preparation comprising a sterol esterase/lipase immobilised covalently on surfa...
|
|
WO/2018/233197A1 |
A low GI brown sugar and a preparation method therefor. A sucrose isomerase and a glucose isomerase are immobilized on bagasse biochar at a certain ratio to form a bagasse biochar immobilized enzyme, and cane juice is transformed by the ...
|
|
WO/2018/227644A1 |
Provided is a method for catalyzing steroidal biological transformation. In the method, sodium alginate-grafted cyclodextrin immobilized cells are used as a catalyst, so as to implement the cyclic utilization of a cyclodextrin medium, th...
|
|
WO/2018/231704A1 |
Provided herein are processes for the preparation 6-bromonicotinamide.
|
|
WO/2018/231704A8 |
Provided herein are processes for the preparation 6-bromonicotinamide.
|
|
WO/2018/226901A1 |
A living tissue model device includes: a first liquid compartment storing a liquid composition; a second liquid compartment storing a liquid composition; and a cell layered body disposed between the first liquid compartment and the secon...
|
